FNY Investment Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-640,032
Closed -$63.6M 1255
2019
Q3
$63.6M Buy
640,032
+196,829
+44% +$18.7M 19.43% 1
2019
Q2
$41M Buy
443,203
+312,548
+239% +$29.7M 12.08% 3
2019
Q1
$12.3M Buy
+130,655
New +$11.4M 4.22% 6
2018
Q4
Sell
-244
Closed -$21K 1261
2018
Q3
$21K Buy
+244
New +$21.6K ﹤0.01% 459

Other funds holding CELG

FNY Investment Advisers's CELG Position: Q4 2019 in Review

FNY Investment Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 640,032 shares — an estimated $63.6M sold.

FNY Investment Advisers first reported a position in CELG in Q3 2018 and held it in 4 quarters. The position peaked at $63.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • FNY Investment Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 640,032 Celgene Corp shares in Q4 2019, an estimated $63.6M.
  • FNY Investment Advisers first reported a position in Celgene Corp in Q3 2018 and held it in 4 quarters.
  • FNY Investment Advisers's Celgene Corp position peaked at $63.6M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.